Lv61
2360 积分 2022-04-14 加入
Tuberculosis and inflammatory bowel disease
12天前
已关闭
Mirikizumab for inducing and maintaining clinical remission in ulcerative colitis
2个月前
已关闭
P738 Response to etrasimod treatment in ulcerative colitis is associated with a reduction of circulating B and pro-inflammatory T cells: a single-cell-based post-hoc sub-analysis of the ELEVATE UC 52 trial
2个月前
已关闭
Beyond endoscopic mucosal healing in UC: histological remission better predicts corticosteroid use and hospitalisation over 6 years of follow-up
2个月前
已完结
Ulcerative Colitis
2个月前
已完结
粪钙卫蛋白检测规范化及其在炎症性肠病中应用的专家共识（2025年·西安）
5个月前
已关闭
Primary sclerosing cholangitis
5个月前
已完结
Primary sclerosing cholangitis
5个月前
已关闭
维得利珠单抗对炎症性肠病患者的短期疗效及安全性
7个月前
已完结
维得利珠单抗对炎症性肠病患者的短期疗效及安全性
7个月前
已关闭
皖公网安备34019202002308
